期刊文献+

局部晚期非小细胞肺癌三维适型放疗同期NP方案化疗的临床分析 被引量:3

Clinical study on three-dimensional conformal radiation therapy and synchronization NP chemotherapy in locally advanced non-small cell lung cancer
原文传递
导出
摘要 目的:评价三维适型放疗联合NP方案同期化疗治疗不能手术切除的局部晚期(ⅢA、ⅢB)非小细胞肺癌(NSCLC)的疗效及毒副反应。方法:86例局部晚期NSCLC患者随机分为三维适型放疗同期化疗组(40例,同期组)及三维适型放疗、化疗序贯治疗组(46例,序贯组),放疗剂量64Gy,化疗方案为NP方案,长春瑞滨25mg/m2,静脉滴入,d1、d8;顺铂25mg/m2,静脉滴入,d1~d3,每3周重复1次。结果:86例全部完成治疗,同期组和序贯组总有效率分别为85.0%(34/40)和76.1%(35/46),P<0.05;1年生存率分别为67.5%(27/40)和60.9%(28/46),P<0.05。同期和序贯组Ⅲ~Ⅳ度骨髓抑制分别为22.5%(9/40)和21.7%(10/46),P>0.05;Ⅱ、Ⅲ级放射肺炎分别为10.0%(4/40)和8.7(4/46),P>0.05;Ⅱ、Ⅲ期放射性食管炎分别为22.5%(9/40)和19.5%(9/46),P>0.05。结论:三维适型放疗同期化疗较序贯治疗能明显提高肿瘤的局控率,改善生存率,毒副反应无明显增加。 OBJECTIVE:To evaluate the efficiency and site effects of the three-dimensional conformal radiation therapy and synchronization NP chemotherapy in locally advanced non-small cell lung cancer. METHODS: Eighty-six cases of locally advanced non-small cell lung cancer were randomly divided into the three-dimensional conformal radiation and synchronization NP chemical therapy (synchronization group, 40 cases) and the three-dimensional conformal radiation and sequence NP chemical therapy (sequence group, 46 cases). The radiation dose was 64 Gy. The chemical therapy scheme was NVB and DDP (NVB25 mg/m^2, d1,d8; DDP 25 mg/m^2, d1-d3). The course of treatment was 3 weeks. RESULTS: Eighty-six cases were all completed. The cumulative survival rates in the cynchronization group and the sequencegroup were 85. 0%(34/40) and 76.1%(35/46) respectively, P〈0. 05; 1 year cumulative survival rates were 67. 5% (27/40) and 60. 9% (28/46) respectively, P〈0.05. The inhibition rates of bone marrow stage Ⅲ and Ⅳ were 22.5 % (9/40) and 21.7% (10/46) respectively (P〉0.05), the rates of stage Ⅱ and Ⅲ of radioactive pneumonia were 10.0% (4/40) and 8. 7% (4/46), P〉0.05, the stage Ⅱ and m of radioactive esophagitis were 22.5%(9/40) and 19.5% (9/46) respectively,P〉0.05. CONCLUSION: The three-dimensional conformal radiation and synchronization NP chemical therapy obviously increases tumour local control rate and is superior to the three-dimensional conformal radiation and sequence chemical therapy, in greatly improving survival rate, and the poison and side effects are not obviously increased.
出处 《中华肿瘤防治杂志》 CAS 2009年第10期782-784,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 非小细胞肺 放射疗法 适形 药物疗法 预后 carcinoma, non-small cell lung radiotherapy, conformal drug therapy prognosis
  • 相关文献

参考文献7

  • 1蒋国梁.非小细胞肺癌的放疗新技术[M]//中国临床肿瘤教育专辑.北京:中国协和医疗大学出版社,2006:80-83.
  • 2王颖杰,王绿化,王鑫,冯勤付,张红星,肖泽芬,殷蔚伯.91例非小细胞肺癌三维适形放疗的临床分析[J].中华放射肿瘤学杂志,2005,14(4):241-244. 被引量:48
  • 3Waller D, Poake M D, Stephens R J, et al. Chemotherapy/or patients with non-small cell lung cancer[J]. Eur J Cardio Thorac Surg,2004,26(12) :173-182.
  • 4Choy H, Curran W, Scott C B, et al. Preliminary report of locally Advanced multimodality potocol (LAMP): a randomized phase Ⅱ study of three chino-radiotherapy reqimens with paclitaxel, carblplatin and thoracic radiotherapy for patients with loall advanced non-small cell lung cancer[J]. Pro Am Soc Clin One, 2003,21(6) :291a.
  • 5Thirion P, Holmbezg O, Collins C D, et al. Escalated does for non-small-cell lung cancer with accelerated hypotraetionated three-dimensional conformal radiation therapy [J]. Radiother Oncol,2004,71(2) : 163-166.
  • 6张力.晚期非小细胞肺癌放疗新进展[M]//中国临床肿瘤学教育专辑.北京:中国海洋大学出版社,2005:111-114.
  • 7孙建湘,莫清华,周隆军,廖彬生.三维适形加量放疗联合化疗治疗非小细胞肺癌的临床观察[J].中华肿瘤防治杂志,2007,14(24):1889-1890. 被引量:11

二级参考文献14

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Rowell NP, Williams CJ. Radical Radiotherapy for stage Ⅰ / Ⅱ non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable ). The Cochrane Library,2001,2:1-11.
  • 3Perez CA, Stanley K, Rubin P,et al.A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of noperable non-oat cell carcinoma of the lung: preliminary report by RTOG. Cancer, 1980,45: 2744-2753.
  • 4Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable nonoat cell carcinoma of the lung treated with definitive radiotherapy: report by the RTOG. Cancer,1987,59:1874-1881.
  • 5Sibley GS, Mundt AJ, Shapiro C, et al. The treatment of stage Ⅲ non-small cell lung cancer using high dose conformal radiothetapy. Int J Radiat Oncol Biol Phys, 1995,33:1001-1007.
  • 6Armtrong J, Raben A, Zelefsky M, et al. Promising survival with 3-dimensional conformal radiation therapy for NSCLC. Radiother Oncol,1997,44:17-22.
  • 7Sim S, Rosenzweig KE, Schindelheim R, et al. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of advanced non-small cell lung cancer. Int J R adiat Oncol Biol Phys,2001,51:660-665.
  • 8Bradley JD, Ieumwananonthachai N, Purdy JA. et al. Gross tumor volume, critical prognosic factor in patients treated with three-dimensional conformal radiation therapy for non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys, 2002,52:49-57.
  • 9Hazuka MB,Turrisi AT,Martel MK, et al. Dose escalation in Non-small cell lung cancer using 3-dimensional conformal radiation therapy treatment planning: preliminary results of phase Ⅰ study. Proc Am Soc Clin Oncol, 1994,13:337.
  • 10Socinski MA, Morris DE, Halle JS, et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage ⅢA and Ⅲ B non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol,2004,22:4341-4350.

共引文献57

同被引文献21

  • 1郭凯平,邓超,刘先领,等.局部晚期非小细胞肺癌的三维适形放疗靶区选择对治疗的影响.暨南大学学报(医学版),2008,29(2):187-189.
  • 2Korst R J,Ginsberg R J. Appropriate surgical treatment of resectable non-small-cell lung cancer[J]. World J Surg, 2007,25 (2): 184-188.
  • 3Swann R S,Albain K S,Rusch V R,et al. Phase Ⅲ study of concurrent chemotherapy(CT/RT) vs CT/RT followed by surgical resection for stage Ⅲ A ( pN2 ) non-small-cell lung cancer (NSCLC) :outcomes update of North American Intergroup 0139 [J]. Clin Oncol, 2005,23: 165.
  • 4Stevenson J P. Two commonly used neoadjuvant chemordiothem py regimens for lodcally advanced stage Ⅲ non-small-cell lung carcinoma long-term results and ssociations with pathologic response [J]. Thoma Cardiovasc Surg,2006,127(1) :108-113.
  • 5Lara P N,Goldberg Z, Davies A, et al. Concurrent chemoradioation strategies in the management of unreseetable stage Ⅲ non small cell lung cancer[J]. Clin Lung Cancer, 2007,3 (2) : 42-48.
  • 6Patel S H,Ajlouni M,Chapman R,et al. A prospective phase Ⅱ study of induction carhoplatin and binorelbine followed by concomitant topotecan and accelerated radiotherapy in locally advanced non-small cell lung cancer[J]. Clin Oncol, 2006,24 (18) 7146.
  • 7El-Sharouni S Y,Kal H B, Battermann J J, et al. Sequential versus concurrent chemo-radiotherapy in inoperable stage Ⅲ non small cell lung cancer[J]. Anticancer Res, 2006,26(1B):495-505.
  • 8KORST R J, GINSBERG R J. Appropriates urgieal treatment of reseetablen on-small cell lung cancer [-J-]. World J Surg, 2007,25(2) ,184-188.
  • 9Hans-Hermann Dubben,Hans-Peter Beck-Bornholdt.??Influence of the Timing of a Concomitant Boost During Fractionated Irradiation of Rat Rhabdomyosarcoma R1H(J)Acta Oncologica . 1993 (1)
  • 10Elias A D,Skarin A T,Gonin R,Oliynyk P,Stomper P C,O’Hara C,Socinski M A,Sheldon T,Maggs P,Frei E.Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results. American journal of clinical oncology . 1994

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部